Furthermore, our results also indicated that ITGA2 silencing enhanced the anti-pancreatic cancer cell proliferation effect of TGF-β treatment, and the combined treatment might represent a novel therapeutic strategy for pancreatic cancer. The gene discussed is TGFB1; the disease is pancreatic neoplasm.